Back to top

BILL NO. 140

(as introduced)

1st Session, 64th General Assembly
Nova Scotia
71 Elizabeth II, 2022

 

Private Member's Bill

 

Fair Drug Pricing Act
(amended)

 

Susan Leblanc
Dartmouth North



First Reading: April 6, 2022

(Explanatory Note)

Second Reading:

Third Reading:

Explanatory Note

This Bill amends the Fair Drug Pricing Act to provide coverage for antiviral drugs for the purpose of pre-exposure prophylaxis from HIV with no copayment.

An Act to Amend Chapter 7
of the Acts of 2011,
the Fair Drug Pricing Act,
Respecting Antiviral Drugs

Be it enacted by the Governor and Assembly as follows:

1 This Act may be cited as the Antiviral Drug Act.

2 Chapter 7 of the Acts of 2011, the Fair Drug Pricing Act, is amended by adding immediately after Section 10 the following Section:

    10A (1) Notwithstanding subsection 10(1), antiviral drugs for the purpose of pre-exposure prophylaxis from human immunodeficiency viruses are deemed to be a benefit.

    (2) No copayment may be charged in connection with antiviral drugs for the purpose of pre-exposure prophylaxis from human immunodeficiency viruses.

 


This page and its contents published by the Office of the Legislative Counsel, Nova Scotia House of Assembly, and © 2022 Crown in right of Nova Scotia. Created April 6, 2022. Send comments to legc.office@novascotia.ca.